Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease. | Clin Nutr | 2023 | 37788561 | PubTator, text mining | PubMed |
| Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related HCC. | Hepatol Commun | 2023 | 37782459 | PubTator, text mining | PubMed |
| Compensated liver cirrhosis: Natural course and disease-modifying strategies. | World J Methodol | 2023 | 37771878 | PubTator, text mining | PubMed |
| Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis. | Front Pharmacol | 2023 | 37771721 | PubTator, text mining | PubMed |
| β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion. | Front Oncol | 2023 | 37771444 | PubTator, text mining | PubMed |
| Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. | Nutrients | 2023 | 37764771 | PubTator, text mining | PubMed |
| New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk. | Nutrients | 2023 | 37764755 | PubTator, text mining | PubMed |
| Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease. | Nutrients | 2023 | 37764663 | PubTator, text mining | PubMed |
| Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease-Oxidative Stress and Inflammation Relevance. | Medicina (Kaunas) | 2023 | 37763733 | PubTator, text mining | PubMed |
| Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation. | Life (Basel) | 2023 | 37763206 | PubTator, text mining | PubMed |
| Present and Future of Dyslipidaemia Treatment-A Review. | J Clin Med | 2023 | 37762780 | PubTator, text mining | PubMed |
| Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2023 | 37762592 | PubTator, text mining | PubMed |
| A Machine Learning-Based Method for Detecting Liver Fibrosis. | Diagnostics (Basel) | 2023 | 37761319 | PubTator, text mining | PubMed |
| SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease. | Biomedicines | 2023 | 37760857 | PubTator, text mining | PubMed |
| Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles? | Biomedicines | 2023 | 37760846 | PubTator, text mining | PubMed |
| Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. | Biomolecules | 2023 | 37759756 | PubTator, text mining | PubMed |
| Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention. | Hepatol Commun | 2023 | 37756016 | PubTator, text mining | PubMed |
| Advances in genetic variation in metabolism-related fatty liver disease. | Front Genet | 2023 | 37753315 | PubTator, text mining | PubMed |
| Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. | Nat Med | 2023 | 37749332 | PubTator, text mining | PubMed |
| Alcohol-Associated Liver Disease: Evolving Concepts and Treatments. | Drugs | 2023 | 37747685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=30